CVS Health Corp. (CVS)
$94.11+1.17%Close
SELLBEAR · day 14
Key stats
Short interest · FINRA settlement 2026-07-31
52-week IV19.5%–66.4%
- Market cap
- $120.1B
- Avg volume
- 8.2M
- Beta
- 0.60
- Div yield
- 2.83%
- P/E (TTM)
- 24.57
- IV-%ile
- 17
- IV ATM
- 26.3%
- Short % float
- 1.47%
- Days to cover
- 2.4
- SI change
- -4.3%
- 1W
- +0.11%
- 1M
- -12.65%
- 3M
- +0.91%
- YTD
- +17.45%
- vs SPY 1W
- +1.30%
- vs SPY 1M
- -15.97%
- vs SPY 3M
- -1.48%
- vs SPY YTD
- +5.69%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- WAYBUYWaystar Holding Corp.RECOVERYQ 14$25.35+1.36%
- GEHCBUYGE HealthCare Technologies Inc.RECOVERYQ 8$74.19-0.84%
- ATRSELLAptarGroup, Inc.RECOVERYQ 16$134.75-0.04%
- VCYTSELLVeracyte, Inc.CRISISQ 15$41.47-1.99%
- BSXBUYBoston Scientific CorporationRECOVERYQ 7$49.01-2.70%
- ZBHBUYZimmer Biomet Holdings, Inc.RECOVERYQ 9$100.98+0.00%
- INMDSELLInMode Ltd.BULLQ 16$15.10+0.27%
- ADUSBUYAddus HomeCare CorporationBULLQ 19$120.82+0.01%
- INFUBUYInfuSystem Holdings, Inc.BULLQ 13$11.95-2.13%
- ELVBUYElevance Health Inc.RECOVERYQ 15$402.63+0.52%
- MGTXBUYMeiraGTx Holdings plcBULLQ 9$14.83+3.42%
- AMPHBUYAmphastar Pharmaceuticals, Inc.RECOVERYQ 7$21.52-0.37%
Industry peers
FMP comparable companies · ranked by market cap
- VRTXBUYVertex Pharmaceuticals Incorporated$139.1BBULLQ 23$548.05-0.08%
- BMYBUYBristol-Myers Squibb Company$136.9BBULLQ 6$67.01+0.40%
- MDTBUYMedtronic plc$119.5BRECOVERYQ 12$93.35-0.48%
- GSKBUYGSK plc$105.0BRECOVERYQ 6$52.41-1.11%
- MCKBUYMcKesson Corporation$100.6BRECOVERYQ 12$858.90+1.73%
- HCABUYHCA Healthcare, Inc.$92.9BRECOVERYQ 24$429.19+0.28%
- ELVBUYElevance Health Inc.$86.9BRECOVERYQ 15$400.54+0.52%
- CISELLCigna Corporation$73.3BRECOVERYQ 12$277.51+1.06%
- CORBUYCencora, Inc.$61.9BRECOVERYQ 20$318.04+1.80%
- HUMSELLHumana Inc.$45.5BBEARQ 10$378.87+2.04%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 35
- VALUE
- 46
- GROWTH
- 37
- GARP
- 7
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC3.9%
REV YoY-
ROE6.4%
EPS YoY-
ROA1.9%
GROSS14
OP2
NET1
[VALUATION]
P/E TTM24.57
P/E FWD-
SECTOR PE22.66
INDUSTRY PE65.78
P/B1.51
P/FCF-
EV/EBITDA13.80
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E95.74
ALTMAN Z-
CURR RATIO0.87
ND/EBITDA-
BETA0.60



















